Tumor progression in waiting time for radiotherapy in head and neck cancer

Radiotherapy and Oncology

Volumn 84, Issue 1, 2007, Pages 5-10

  Jensen, Anni Ravnsbæk ^a   Nellemann, Hanne Marie ^b   Overgaard, Jens ^a  

^a Department of Experimental Clinical Oncology ^*  (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Delay; Head and neck cancer; Radiotherapy; Tumor volume doubling time; Waiting time

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST; FEMALE; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; THERAPY DELAY; TISSUE DIFFERENTIATION; TREATMENT PLANNING; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; TIME FACTORS; TUMOR BURDEN; WAITING LISTS;

EID: 34447105686     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.04.001     Document Type: Article

References (29)

1. Primdahl H., Nielsen A.L., Larsen S., Andersen E., Ipsen M., Lajer C., et al. Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA. Acta Oncol 45 (2006) 156-161
2. Robinson D., Massey T., Davies E., Jack R.H., Sehgal A., and Moller H. Waiting times for radiotherapy: variation over time and between cancer networks in southeast England. Br J Cancer 92 (2005) 1201-1208
3. Rutqvist L.E. Waiting times for cancer patients - a "slippery slope" in oncology. Acta Oncol 45 (2006) 121-123
4. Barton M.B., Morgan G., Smee R., Tiver K.W., Hamilton C., and Gebski V. Does waiting time affect the outcome of larynx cancer treated by radiotherapy?. Radiother Oncol 44 (1997) 137-1341
5. Fortin A., Bairati I., Albert M., Moore L., Allard J., and Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 929-936
6. Huang J., Barbera L., Brouwers M., Browman G., and Mackillop W.J. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21 (2003) 555-563
7. Hansen O., Larsen S., Bastholt L., Godballe C., and Jorgensen K.E. Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients. Int J Radiat Oncol Biol Phys 61 (2005) 789-794
8. Brouha X.D., Op De C.B., Terhaard C.H., and Hordijk G.J. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma?. Clin Otolaryngol Allied Sci 25 (2000) 215-218
9. Overgaard J., Hansen H.S., Jorgensen K., and Hjelm H.M. Primary radiotherapy of larynx and pharynx carcinoma-an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 12 (1986) 515-521
10. Bentzen S.M., Johansen L.V., Overgaard J., and Thames H.D. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 20 (1991) 1197-1206
11. Bentzen S.M., and Thames H.D. Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys 36 (1996) 247-251
12. Johansen L.V., Grau C., and Overgaard J. Glottic carcinoma-patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol 63 (2002) 257-267
13. Lindeloev B., and Hansen H.S. The impact of lymph node metastases on the results of treatment by primary radiotherapy and secondary surgery in oropharyngeal cancer. Acta Oncol 34 (1995) 965-968
14. Vergeer M.R., Doornaert P., Leemans C.R., Buter J., Slotman B.J., and Langendijk J.A. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 79 (2006) 39-44
15. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Nat Cancer Inst 92 (2000) 205-216
16. UICC, TNM classification of Malignant Tumours, 5th edition. 1997.
17. Wildt J., Bundgaard T., and Bentzen S.M. Delay in the diagnosis of oral squamous cell carcinoma. Clin Otolaryngol 20 (1995) 21-25
18. Crawford S.C., Davis J.A., Siddiqui N.A., de C.L., Gillis C.R., Hole D., et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 325 (2002) 196
19. Waaijer A., Terhaard C.H., Dehnad H., Hordijk G.J., van Leeuwen M.S., Raaymakers C.P., et al. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol 66 (2003) 271-276
20. Wyatt R.M., Beddoe A.H., and Dale R.G. The effects of delays in radiotherapy treatment on tumour control. Phys Med Biol 48 (2003) 139-155
21. Mackillop W.J., Bates J.H., O'Sullivan B., and Withers H.R. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys 34 (1996) 243-250
22. Overgaard J., and Horsman M.R. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Sem Rad Oncol 6 (1996) 10-21
23. Wadsley J.C., and Bentzen S.M. Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys 60 (2004) 1405-1409
24. Overgaard J., Hansen H.S., Overgaard M., Bastholt L., Berthelsen A., Specht L., et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 46 (1998) 135-146
25. Overgaard J., Hansen H.S., Specht L., Overgaard M., Grau C., Andersen E., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
26. Bourhis J., Overgaard J., Audry H., Ang K.K., Saunders M., Bernier J., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
27. Dammann F., Horger M., Mueller-Berg M., Schlemmer H., Claussen C.D., Hoffman J., et al. Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. Am J Roentgenol 184 (2005) 1326-1331
28. Withers H.R., Taylor J.M., and Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 14 (1988) 751-759
29. Bentzen S.M., Saunders M.I., Dische S., and Bond S.J. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60 (2001) 123-135